STAAR Surgical Company announced on August 4, 2025, that it has entered a Merger Agreement with Alcon Research, LLC, under which each share of STAAR common stock will be converted to $28.00 in cash, subject to stockholder approval and regulatory conditions. The stockholder meeting for the vote will be scheduled later.